biote Statistics
Total Valuation
biote has a market cap or net worth of $56.76 million. The enterprise value is $141.17 million.
Important Dates
The last earnings date was Wednesday, March 11, 2026, after market close.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 39.55 million shares outstanding. The number of shares has increased by 6.99% in one year.
| Current Share Class | 30.71M |
| Shares Outstanding | 39.55M |
| Shares Change (YoY) | +6.99% |
| Shares Change (QoQ) | -16.02% |
| Owned by Insiders (%) | 13.17% |
| Owned by Institutions (%) | 44.74% |
| Float | 21.39M |
Valuation Ratios
The trailing PE ratio is 1.95 and the forward PE ratio is 6.11.
| PE Ratio | 1.95 |
| Forward PE | 6.11 |
| PS Ratio | 0.29 |
| Forward PS | 0.27 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.83 |
| P/OCF Ratio | 1.57 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 3.76, with an EV/FCF ratio of 4.68.
| EV / Earnings | 5.22 |
| EV / Sales | 0.73 |
| EV / EBITDA | 3.76 |
| EV / EBIT | 4.03 |
| EV / FCF | 4.68 |
Financial Position
The company has a current ratio of 1.22
| Current Ratio | 1.22 |
| Quick Ratio | 0.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 3.64 |
| Interest Coverage | 3.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 19.06% |
| Return on Invested Capital (ROIC) | 122.09% |
| Return on Capital Employed (ROCE) | 56.00% |
| Weighted Average Cost of Capital (WACC) | 9.10% |
| Revenue Per Employee | $885,802 |
| Profits Per Employee | $124,631 |
| Employee Count | 217 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 2.96 |
Taxes
In the past 12 months, biote has paid $5.99 million in taxes.
| Income Tax | 5.99M |
| Effective Tax Rate | 15.93% |
Stock Price Statistics
The stock price has decreased by -60.90% in the last 52 weeks. The beta is 1.14, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -60.90% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 23.67 |
| Average Volume (20 Days) | 198,937 |
Short Selling Information
The latest short interest is 1.44 million, so 3.64% of the outstanding shares have been sold short.
| Short Interest | 1.44M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 3.64% |
| Short % of Float | 6.73% |
| Short Ratio (days to cover) | 10.17 |
Income Statement
In the last 12 months, biote had revenue of $192.22 million and earned $27.05 million in profits. Earnings per share was $0.74.
| Revenue | 192.22M |
| Gross Profit | 137.36M |
| Operating Income | 35.07M |
| Pretax Income | 37.58M |
| Net Income | 27.05M |
| EBITDA | 37.54M |
| EBIT | 35.07M |
| Earnings Per Share (EPS) | $0.74 |
Full Income StatementBalance Sheet
The company has $24.12 million in cash and $109.92 million in debt, with a net cash position of -$85.80 million or -$2.17 per share.
| Cash & Cash Equivalents | 24.12M |
| Total Debt | 109.92M |
| Net Cash | -85.80M |
| Net Cash Per Share | -$2.17 |
| Equity (Book Value) | -50.40M |
| Book Value Per Share | -1.91 |
| Working Capital | 9.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $35.19 million and capital expenditures -$5.02 million, giving a free cash flow of $30.18 million.
| Operating Cash Flow | 35.19M |
| Capital Expenditures | -5.02M |
| Free Cash Flow | 30.18M |
| FCF Per Share | $0.76 |
Full Cash Flow StatementMargins
Gross margin is 71.46%, with operating and profit margins of 18.24% and 14.07%.
| Gross Margin | 71.46% |
| Operating Margin | 18.24% |
| Pretax Margin | 19.55% |
| Profit Margin | 14.07% |
| EBITDA Margin | 19.53% |
| EBIT Margin | 18.24% |
| FCF Margin | 15.70% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.99% |
| Shareholder Yield | -6.99% |
| Earnings Yield | 48.84% |
| FCF Yield | 54.50% |
Analyst Forecast
The average price target for biote is $2.25, which is 56.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.25 |
| Price Target Difference | 56.79% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.23% |
| EPS Growth Forecast (5Y) | 12.20% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.76 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 7 |
